Crossmark

Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-07915-2

Published Online: 2024-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kemper, Gijs http://orcid.org/0000-0002-1693-2676
Gerges, Christian

Schoon, Erik J.

Schreuder, Ramon-Michel

Schrauwen, Ruud R. W.

Epping, Ludger S. M.

Beyna, Torsten

Drenth, Joost P. H.

Gündug, Ufuk

Siersema, Peter D.

van Geenen, Erwin J. M.

,
Funding

Funding for this research was provided by:

Interreg North-West Europe
License Information

Text and Data Mining valid from 2024-02-17

Version of Record valid from 2024-02-17
More Information

Article History

Received: 22 June 2023

Accepted: 9 January 2024

First Online: 17 February 2024

Declarations

:

: All patients who participate in the RESPECT study need to give written informed consent prior to the EMR. Ethical approval of the study protocol has been obtained from the accredited Medical Research Ethics Committee (METC) of the region Arnhem-Nijmegen, the Netherlands (reference number 2020–7272). The protocol is registered on ClinicalTrial.gov with reference number NCT05121805. This study is performed in line with the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below